RhumbLine Advisers’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $202K | Sell |
7,286
-55,414
| -88% | -$1.53M | ﹤0.01% | 3224 |
|
|
2025
Q1 | $1.39M | Buy |
62,700
+3,745
| +6% | +$83.2K | ﹤0.01% | 2011 |
|
|
2024
Q4 | $1.17M | Sell |
58,955
-909
| -2% | -$18K | ﹤0.01% | 2171 |
|
|
2024
Q3 | $1.5M | Buy |
59,864
+3,798
| +7% | +$94.9K | ﹤0.01% | 2052 |
|
|
2024
Q2 | $1.05M | Sell |
56,066
-5,365
| -9% | -$100K | ﹤0.01% | 2217 |
|
|
2024
Q1 | $1.21M | Buy |
61,431
+494
| +0.8% | +$9.75K | ﹤0.01% | 2145 |
|
|
2023
Q4 | $1.07M | Sell |
60,937
-2,196
| -3% | -$38.5K | ﹤0.01% | 2212 |
|
|
2023
Q3 | $1.1M | Buy |
63,133
+3,871
| +7% | +$67.2K | ﹤0.01% | 2151 |
|
|
2023
Q2 | $834K | Buy |
59,262
+13,171
| +29% | +$185K | ﹤0.01% | 2400 |
|
|
2023
Q1 | $496K | Buy |
46,091
+1,681
| +4% | +$18.1K | ﹤0.01% | 2434 |
|
|
2022
Q4 | $665K | Buy |
44,410
+1,427
| +3% | +$21.4K | ﹤0.01% | 2335 |
|
|
2022
Q3 | $552K | Buy |
42,983
+2,939
| +7% | +$37.7K | ﹤0.01% | 2449 |
|
|
2022
Q2 | $388K | Buy |
40,044
+4,650
| +13% | +$45.1K | ﹤0.01% | 2623 |
|
|
2022
Q1 | $352K | Buy |
35,394
+737
| +2% | +$7.33K | ﹤0.01% | 2583 |
|
|
2021
Q4 | $408K | Sell |
34,657
-812
| -2% | -$9.56K | ﹤0.01% | 2593 |
|
|
2021
Q3 | $404K | Sell |
35,469
-968
| -3% | -$11K | ﹤0.01% | 2638 |
|
|
2021
Q2 | $508K | Buy |
36,437
+7,675
| +27% | +$107K | ﹤0.01% | 2560 |
|
|
2021
Q1 | $532K | Sell |
28,762
-1,655
| -5% | -$30.6K | ﹤0.01% | 2469 |
|
|
2020
Q4 | $537K | Buy |
30,417
+4,711
| +18% | +$83.2K | ﹤0.01% | 2415 |
|
|
2020
Q3 | $394K | Buy |
25,706
+2,424
| +10% | +$37.2K | ﹤0.01% | 2397 |
|
|
2020
Q2 | $593K | Buy |
23,282
+6,375
| +38% | +$162K | ﹤0.01% | 2271 |
|
|
2020
Q1 | $262K | Buy |
16,907
+44
| +0.3% | +$682 | ﹤0.01% | 2465 |
|
|
2019
Q4 | $187K | Buy |
16,863
+335
| +2% | +$3.72K | ﹤0.01% | 2767 |
|
|
2019
Q3 | $141K | Sell |
16,528
-38
| -0.2% | -$324 | ﹤0.01% | 2826 |
|
|
2019
Q2 | $224K | Buy |
16,566
+3,755
| +29% | +$50.8K | ﹤0.01% | 2743 |
|
|
2019
Q1 | $231K | Buy |
12,811
+4,862
| +61% | +$87.7K | ﹤0.01% | 2682 |
|
|
2018
Q4 | $223K | Buy |
+7,949
| New | +$223K | ﹤0.01% | 2681 |
|